Midnight by Tikum Olam
Unknown
Midnight is a sativa-dominant cultivar developed by Tikum Olam, known for its CBD-forward profile and low THC content. It was created in Israel to provide symptom relief with minimal intoxication, making it suitable for daytime use.
Appearance
Midnight typically presents a medium to tall stature with a sativa-like structure, featuring elongated branches and moderate internodal spacing. The flowers are often medium-sized and conical, with a calyx-forward appearance. Bud colors can range from olive to lime green, accented by golden or pale apricot pistils. Resin coverage is ample, contributing to a clean and classic aesthetic.
The buds are generally trim-friendly, with a structure that allows for good air circulation. Proper post-harvest handling aims for consistent moisture content and water activity to preserve pliability and aromatic integrity. Cured flowers retain a bright appearance with intact gland heads.
Aroma & Flavor
The aroma of Midnight is characterized by bright and herbal notes, including layered scents of citrus zest, pine needles, and light florals. Initial impressions often reveal a lemon-lime lift accompanied by fresh greenery. Secondary notes can include sweet herbs, a hint of eucalyptus, and a subtle peppery quality.
Flavors often mirror the aroma, with prominent citrus and lemon notes, complemented by herbal and floral undertones. Some users may detect hints of mango or mint. The overall profile is clean and uplifting, avoiding heavy or musky characteristics.
Effects
Midnight is designed to provide a balanced and functional effect profile, promoting calm and focus. Its CBD-dominant nature helps to modulate the psychoactive effects of THC, leading to attenuated intoxication and a clearer cognitive state.
This strain is favored for daytime use, as it aims to reduce discomfort without causing significant mental fog or heavy impairment. Patients often report feeling more composed and comfortable, allowing for engagement in daily tasks.
Terpenes & Cannabinoids
Midnight is recognized as a Type II chemotype, featuring significant levels of both CBD and THC, with CBD typically being the dominant cannabinoid. Public summaries often indicate averages around 10% CBD and approximately 7% THC.
The terpene profile is associated with notes of Myrcene, Limonene, Caryophyllene, Pinene, and Terpinolene. Pinene is linked to mental clarity, Limonene can contribute to a buoyant mood, and Caryophyllene adds subtle spicy notes.
Growing
Midnight exhibits sativa-leaning morphology, characterized by a medium-to-tall stature, elongated branches, and narrower leaflets. It benefits from training to manage its apical dominance and promote even canopy development. The plant's airy structure is conducive to good light penetration and can help reduce humidity risks when managed properly.
Flowering time and yield details are not specified in the source notes. The cultivar is noted for favorable agricultural traits and structural stability under intensive cultivation, suggesting a reliable growing process.
Origins & Lineage
Midnight was developed by Tikum Olam, an Israeli medical cannabis pioneer, and emerged within Israel's regulated patient program during the 2010s. Its specific genetic lineage has not been publicly disclosed by the breeder, which is common for proprietary medical cultivars.
The strain is characterized by its mostly sativa heritage and a CBD-forward, low-to-moderate THC expression. It was bred with the goals of functional daytime usability, consistent cannabinoid ratios, and favorable agricultural traits, aiming for symptom relief with attenuated psychoactivity.